Shanda Asset Management Holdings LTD Glaukos Corp Transaction History

Shanda Asset Management Holdings LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$26.05 - $34.5 $1.27 Million - $1.68 Million	-48,804 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.5 - $36.01 $460,698 - $677,132	18,804 Added 62.68%	48,804 $1.25 Million
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $937,800 - $1.26 Million	30,000	30,000 $990,000

273

43.6M

89.8K

236K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $5.68B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Shanda Asset Management Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Shanda Asset Management Holdings LTD with notifications on news.